What is the ticker symbol for Taysha Gene Therapies, Inc.?

The ticker symbol for Taysha Gene Therapies, Inc. is NASDAQ:TSHA

Does Taysha Gene Therapies, Inc. pay dividends?

No, Taysha Gene Therapies, Inc. does not pay dividends

What sector is Taysha Gene Therapies, Inc. in?

Taysha Gene Therapies, Inc. is in the Healthcare sector

What industry is Taysha Gene Therapies, Inc. in?

Taysha Gene Therapies, Inc. is in the Biotechnology industry

What country is Taysha Gene Therapies, Inc. based in?

Taysha Gene Therapies, Inc. is headquartered in United States

When did Taysha Gene Therapies, Inc. go public?

Taysha Gene Therapies, Inc. initial public offering (IPO) was on September 24, 2020

Is Taysha Gene Therapies, Inc. in the S&P 500?

No, Taysha Gene Therapies, Inc. is not included in the S&P 500 index

Is Taysha Gene Therapies, Inc. in the NASDAQ 100?

No, Taysha Gene Therapies, Inc. is not included in the NASDAQ 100 index

Is Taysha Gene Therapies, Inc. in the Dow Jones?

No, Taysha Gene Therapies, Inc. is not included in the Dow Jones index

When was Taysha Gene Therapies, Inc. last earnings report?

Taysha Gene Therapies, Inc.'s most recent earnings report was on August 11, 2026

When does Taysha Gene Therapies, Inc. report earnings?

The next expected earnings date for Taysha Gene Therapies, Inc. is November 4, 2026

TSHA Stock Financials, Chart, Sentiment & Profile

Summary

Current Price: As of today, TSHA price is $5.60, up +0.54% on September 4, 2026
Current Price All-Time High: TSHA price is currently -83.21% below its historical high of $33.35 set on January 19, 2021
Market Cap: TSHA current market cap is $2B, up +105.23% over the past 365 days
Revenue: TSHA current annual revenue is $9.77M, up +17.28% year-over-year
Next Earnings: The next earnings release for TSHA is on November 4, 2026

Profile

Company profile for Taysha Gene Therapies, Inc. (TSHA)
Metric	Value
Full Name	Taysha Gene Therapies, Inc.
Ticker	NASDAQ: TSHA
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology
Country	United States
IPO	Sep 24, 2020
Indexes	Not included
Website	tayshagtx.com
Employees	73

Key Metrics

Taysha Gene Therapies, Inc. Key Details
Metric	Value	Date
Price	$5.60	Sep 4, 26
Price, 1D Change	+0.54%	Sep 4, 26
	$2B	Sep 4, 26
	-	Sep 4, 26
	-	Sep 4, 26
	1.83	Sep 4, 26
	$9.77M	Dec 31, 25
Revenue, 1Y Change	+17.28%	Dec 31, 25
	-$0.34	Dec 31, 25
EPS, 1Y Change	+4.51%	Dec 31, 25

Events

Taysha Gene Therapies, Inc. Events
Metric	Value	Date
Next Earnings		Nov 4, 26
Last Qtr. Earnings		Aug 11, 26
Last Ann. Earnings		Feb 26, 25
Last Ex-Dividend	N/A	N/A
Next Ex-Dividend	N/A	N/A
Last Split	N/A	N/A
Next Split	N/A	N/A
Last Ticker Change	N/A	N/A
Next Ticker Change	N/A	N/A

🔒 Log In To Unlock Full Data

Estimates

TSHA Estimates
Metric	Value	Date
	-$0.34	Dec 31, 25
EPS Estimate	-$0.47	N/A
EPS Est. Change	-39.04%	N/A
	$9.77M	Dec 31, 25
Revenue Estimate	$1.75M	N/A
Revenue Est. Change	-82.09%	N/A
Current Price	$5.60	Sep 4, 26
Price Target	$12.50	-
Price Tgt. Change	+123.21%	-

🔒 Log In To Unlock Full Data

EPS

TSHA EPS reported versus estimate values
Year	Estimate	Reported	Surprise / Exp.
2024	-$0.31	-$0.36	-15.16%
2025	-$0.34	-$0.34	-1.25%
2026	-$0.47	N/A	-39.04%
2027	-$0.46	N/A	-35.67%

Revenue

TSHA revenue reported versus estimate values chart
Year	Estimate	Reported	Surprise / Exp.
2024	$8.25M	$8.33M	+1.06%
2025	$6.30M	$9.77M	+55.11%
2026	$1.75M	N/A	-82.09%
2027	$19.65M	N/A	+101.09%

🔒 Log In To Unlock Full Data

Performance

TSHA Performance
Metric	Value	Date
Price, 1Y	+71.78%	Sep 4, 26
Price, 3Y	+54.27%	Sep 4, 26
	+105.23%	Sep 4, 26
	+680.14%	Sep 4, 26
	+17.28%	Dec 31, 25
	+290.61%	Dec 31, 25
	+4.51%	Dec 31, 25
	+90.97%	Dec 31, 25

🔒 Log In To Unlock Full Data

Technicals

TSHA Technical Indicators
Metric	Value	Date
Current Price	$5.60	Sep 4, 26
	$5.44	Sep 4, 26
	$6.06	Sep 4, 26
	$5.35	Sep 4, 26
	$5.97	Sep 4, 26
	-$0.12	Sep 4, 26
	1.83	Sep 4, 26
	$0.32	Sep 4, 26
	40.81	Sep 4, 26
	31.97%	Sep 4, 26

Dividends

TSHA Dividends
Metric	Value	Date
	-	N/A
Upcoming	N/A	N/A
	-	Sep 4, 26
	-	Dec 31, 25
	$0.00	Dec 31, 25
	0.00%	Dec 31, 25

🔒 Log In To Unlock Full Data

Income & Profitability

TSHA Income & Profitability
Metric	Value	Date
	$9.77M	Dec 31, 25
	-$0.34	Dec 31, 25
	$0.00	Dec 31, 25
	88.28%	Dec 31, 25
	-$110.50M	Dec 31, 25
	-1,130.65%	Dec 31, 25
	-$109.00M	Dec 31, 25
	-1,115.27%	Dec 31, 25
	-$109.35M	Dec 31, 25

🔒 Log In To Unlock Full Data

Financial Health

TSHA Financial Health
Metric	Value	Date
	0.28	Dec 31, 25
	12.23	Dec 31, 25
	12.23	Dec 31, 25
	-	Dec 31, 25
	-	Jun 30, 26
	2.57	Sep 4, 26

Valuations

TSHA Valuations
Metric	Value	Date
	-	Sep 4, 26
	332.67	Sep 4, 26
	4.71	Sep 4, 26
	-9.18	Sep 4, 26
	-	N/A

Balance Sheet

TSHA Balance Sheet
Metric	Value	Date
	$246.94M	Dec 31, 25
	$320.22M	Dec 31, 25
	$483.73M	Dec 31, 25
	$324.65M	Dec 31, 25
	$236.79M	Dec 31, 25
	$26.55M	Dec 31, 25
	$68.28M	Dec 31, 25
	$2.24M	Dec 31, 25
	$6.28M	Dec 31, 25

Expenses

TSHA Expenses
Metric	Value	Date
	$118.77M	Dec 31, 25
	$110.50M	Dec 31, 25
	$1.15M	Dec 31, 25
	$0.00	Dec 31, 25
	$1.15M	Dec 31, 25
	$0.00	Dec 31, 25
	$0.00	Dec 31, 25

Cash Flow

TSHA Cash Flow
Metric	Value	Date
	-$93.09M	Dec 31, 25
	-$604.00K	Dec 31, 25
	$274.59M	Dec 31, 25
	$738.00K	Dec 31, 25
	-$93.83M	Dec 31, 25

Recent analyst updates

TSHA Recent analyst updates
Metric	Value	Date
Goldman Sachs	→	Jul 21, 26
Citizens	→	Jul 2, 26
Needham	→	Jun 30, 26
Baird	→	Jun 30, 26
Citizens	→	Jun 23, 26
B of A Securities	→	Jun 23, 26
BMO Capital	→	Jun 23, 26
Needham	→	Jun 22, 26
Canaccord Genuity	→	Apr 6, 26
Needham	→	Mar 19, 26

Analyst sentiment

Institutional ownership

Screeners with TSHA

PerformanceOther

IndexesNASDAQ

TechnicalsMoving Averages

Stocks Above SMA 200

TechnicalsOther

Stocks With High Beta

OtherShares

Growing Shares Outstanding

OtherSentiment

OtherMarket cap

Small Cap Stocks

OtherTypes

All Stocks

OtherExchanges

NASDAQ Listed Companies

CountriesOther

US Stocks

Sectors & IndustriesAll Sectors

Healthcare Sector

Sectors & IndustriesAll Industries

Biotech Companies

FAQ

What is the ticker symbol for Taysha Gene Therapies, Inc.?: The ticker symbol for Taysha Gene Therapies, Inc. is NASDAQ:TSHA
Does Taysha Gene Therapies, Inc. pay dividends?: No, Taysha Gene Therapies, Inc. does not pay dividends
What sector is Taysha Gene Therapies, Inc. in?: Taysha Gene Therapies, Inc. is in the Healthcare sector
What industry is Taysha Gene Therapies, Inc. in?: Taysha Gene Therapies, Inc. is in the Biotechnology industry
What country is Taysha Gene Therapies, Inc. based in?: Taysha Gene Therapies, Inc. is headquartered in United States
When did Taysha Gene Therapies, Inc. go public?: Taysha Gene Therapies, Inc. initial public offering (IPO) was on September 24, 2020
Is Taysha Gene Therapies, Inc. in the S&P 500?: No, Taysha Gene Therapies, Inc. is not included in the S&P 500 index
Is Taysha Gene Therapies, Inc. in the NASDAQ 100?: No, Taysha Gene Therapies, Inc. is not included in the NASDAQ 100 index
Is Taysha Gene Therapies, Inc. in the Dow Jones?: No, Taysha Gene Therapies, Inc. is not included in the Dow Jones index
When was Taysha Gene Therapies, Inc. last earnings report?: Taysha Gene Therapies, Inc.'s most recent earnings report was on August 11, 2026
When does Taysha Gene Therapies, Inc. report earnings?: The next expected earnings date for Taysha Gene Therapies, Inc. is November 4, 2026

Data Sources & References

TSHA Official Website www.tayshagtx.com
TSHA Profile on Yahoo Finance finance.yahoo.com/quote/TSHA
TSHA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tsha